Pro:ExpandstreatmentoptionsPro:Lowerslong-termcostsPro:EncouragesefficiencyPro:Improvespatientoutcomes❌Con:ReducescompetitionEdwardsLifesciences✅Pro:ExpandstreatmentoptionsTAVR-ARdevice❌Con:Risk ofmarketmonopoly❌Con:StiflessmallercompetitorsID&E: Riskof bias intechnologyadoptionPro:Drivesinnovation❌Con:Raisescost forconsumers✅Pro:Improvespatientoutcomes✅Pro:Lowerslong-termcostsPro:Promotesfasterdevelopment“Innovation”Con:Raisescost forconsumers✅Pro:EncouragesefficiencyCon: Canlimitinnovation (ifmonopolized)Con: Riskof marketmonopoly🌎ID&E:Could createglobaldisparities🌎ID&E:May reduceequitableaccess ifcosts rise✅Pro:Promotesfasterdevelopment🌎ID&E:Opportunityto designfor inclusionID&E:RegulatoryoversightprotectsfairnessCon:Reducescompetition❌Con: Canlimitinnovation (ifmonopolized)HeartWare❌Con:AntitrustchallengesID&E: CouldcreateglobaldisparitiesCon: StiflessmallercompetitorsCon:Antitrustchallenges🌎ID&E:Increasesaccess tolife-savingdevices“Antitrust”ThoratecID&E:Impactsaffordabilityforunderservedpopulations🌎ID&E:Impactsaffordability forunderservedpopulations🌎ID&E:Regulatoryoversightprotectsfairness“CaseStudyMentioned”“CaseStudyMentioned”ID&E: Mayreduceequitableaccess ifcosts rise“Antitrust”JenaValvePro:Createscompetitiveadvantage🌎ID&E:Risk of biasintechnologyadoptionCon:Potential jobloss insmaller firms✅Pro:Createscompetitiveadvantage✅Pro:Drivesinnovation“Innovation”ID&E:Increasesaccess tolife-savingdevices❌Con:Potential jobloss insmaller firmsID&E:Opportunityto designfor inclusionPro:ExpandstreatmentoptionsPro:Lowerslong-termcostsPro:EncouragesefficiencyPro:Improvespatientoutcomes❌Con:ReducescompetitionEdwardsLifesciences✅Pro:ExpandstreatmentoptionsTAVR-ARdevice❌Con:Risk ofmarketmonopoly❌Con:StiflessmallercompetitorsID&E: Riskof bias intechnologyadoptionPro:Drivesinnovation❌Con:Raisescost forconsumers✅Pro:Improvespatientoutcomes✅Pro:Lowerslong-termcostsPro:Promotesfasterdevelopment“Innovation”Con:Raisescost forconsumers✅Pro:EncouragesefficiencyCon: Canlimitinnovation (ifmonopolized)Con: Riskof marketmonopoly🌎ID&E:Could createglobaldisparities🌎ID&E:May reduceequitableaccess ifcosts rise✅Pro:Promotesfasterdevelopment🌎ID&E:Opportunityto designfor inclusionID&E:RegulatoryoversightprotectsfairnessCon:Reducescompetition❌Con: Canlimitinnovation (ifmonopolized)HeartWare❌Con:AntitrustchallengesID&E: CouldcreateglobaldisparitiesCon: StiflessmallercompetitorsCon:Antitrustchallenges🌎ID&E:Increasesaccess tolife-savingdevices“Antitrust”ThoratecID&E:Impactsaffordabilityforunderservedpopulations🌎ID&E:Impactsaffordability forunderservedpopulations🌎ID&E:Regulatoryoversightprotectsfairness“CaseStudyMentioned”“CaseStudyMentioned”ID&E: Mayreduceequitableaccess ifcosts rise“Antitrust”JenaValvePro:Createscompetitiveadvantage🌎ID&E:Risk of biasintechnologyadoptionCon:Potential jobloss insmaller firms✅Pro:Createscompetitiveadvantage✅Pro:Drivesinnovation“Innovation”ID&E:Increasesaccess tolife-savingdevices❌Con:Potential jobloss insmaller firmsID&E:Opportunityto designfor inclusion

Competitive Technology - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
  1. Pro: Expands treatment options
  2. Pro: Lowers long-term costs
  3. Pro: Encourages efficiency
  4. Pro: Improves patient outcomes
  5. ❌Con: Reduces competition
  6. Edwards Lifesciences
  7. ✅Pro: Expands treatment options
  8. TAVR-AR device
  9. ❌Con: Risk of market monopoly
  10. ❌Con: Stifles smaller competitors
  11. ID&E: Risk of bias in technology adoption
  12. Pro: Drives innovation
  13. ❌Con: Raises cost for consumers
  14. ✅Pro: Improves patient outcomes
  15. ✅Pro: Lowers long-term costs
  16. Pro: Promotes faster development
  17. “Innovation”
  18. Con: Raises cost for consumers
  19. ✅Pro: Encourages efficiency
  20. Con: Can limit innovation (if monopolized)
  21. Con: Risk of market monopoly
  22. 🌎ID&E: Could create global disparities
  23. 🌎ID&E: May reduce equitable access if costs rise
  24. ✅Pro: Promotes faster development
  25. 🌎ID&E: Opportunity to design for inclusion
  26. ID&E: Regulatory oversight protects fairness
  27. Con: Reduces competition
  28. ❌Con: Can limit innovation (if monopolized)
  29. HeartWare
  30. ❌Con: Antitrust challenges
  31. ID&E: Could create global disparities
  32. Con: Stifles smaller competitors
  33. Con: Antitrust challenges
  34. 🌎ID&E: Increases access to life-saving devices
  35. “Antitrust”
  36. Thoratec
  37. ID&E:Impacts affordability for underserved populations
  38. 🌎ID&E:Impacts affordability for underserved populations
  39. 🌎ID&E: Regulatory oversight protects fairness
  40. “Case Study Mentioned”
  41. “Case Study Mentioned”
  42. ID&E: May reduce equitable access if costs rise
  43. “Antitrust”
  44. JenaValve
  45. Pro: Creates competitive advantage
  46. 🌎ID&E: Risk of bias in technology adoption
  47. Con: Potential job loss in smaller firms
  48. ✅Pro: Creates competitive advantage
  49. ✅Pro: Drives innovation
  50. “Innovation”
  51. ID&E: Increases access to life-saving devices
  52. ❌Con: Potential job loss in smaller firms
  53. ID&E: Opportunity to design for inclusion